Whitehawk Therapeutics (WHWK) Receivables: 2020-2024
Historic Receivables for Whitehawk Therapeutics (WHWK) over the last 3 years, with Dec 2024 value amounting to $5.9 million.
- Whitehawk Therapeutics' Receivables rose 7.56% to $5.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $23.3 million, marking a year-over-year increase of 13.94%. This contributed to the annual value of $5.9 million for FY2024, which is 7.56% up from last year.
- According to the latest figures from Q4 2024, Whitehawk Therapeutics' Receivables is $5.9 million, which was down 9.74% from $6.5 million recorded in Q3 2024.
- In the past 5 years, Whitehawk Therapeutics' Receivables registered a high of $14.1 million during Q4 2020, and its lowest value of $1.9 million during Q4 2022.
- Over the past 3 years, Whitehawk Therapeutics' median Receivables value was $5.2 million (recorded in 2023), while the average stood at $4.4 million.
- Per our database at Business Quant, Whitehawk Therapeutics' Receivables skyrocketed by 194.74% in 2023 and then decreased by 11.36% in 2024.
- Quarterly analysis of 4 years shows Whitehawk Therapeutics' Receivables stood at $14.1 million in 2020, then reached $1.9 million in 2022, then surged by 194.74% to $5.5 million in 2023, then grew by 7.56% to $5.9 million in 2024.
- Its Receivables was $5.9 million in Q4 2024, compared to $6.5 million in Q3 2024 and $5.9 million in Q2 2024.